ALIMERA SCIENCES INC (ALIM)


Stock Price Forecast

May 13, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading ALIMERA SCIENCES INC chart...

About the Company

Alimera Sciences, Inc. is a biopharmaceutical sales company based in Alpharetta, Georgia that specializes in the commercialization and sales of prescription ophthalmic pharmaceuticals. The company's main selling focus is on diseases affecting the back of the eye, or retina. The company is the licensee for Iluvien, a fluocinolone acetonide intravitreal implant.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

487

Exchange

Nasdaq

$108M

Total Revenue

487

Employees

$182M

Market Capitalization

-3.21

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $ALIM News

We don't have any news on ALIMERA SCIENCES INC at the moment.

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...